Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) SHH

9.75

+0.01(+0.10%)

Updated at December 05 01:36PM

Currency In CNY

Zhejiang Starry Pharmaceutical Co.,Ltd.

Address

Xianju modern industrial cluster

Xianju, 317300

China

Phone

86 57 6877 18628

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1845

First IPO Date

March 09, 2016

Key Executives

NameTitlePayYear Born
Wentao HuangAccounting Supervisor0N/A
Mr. Chaoyang YaoDeputy General Manager01980
Mr. Junfeng GuoSecretary & Chief Financial Officer01985
Mr. Chun YeDeputy General Manager01979
Mr. Weiyi ShenVice Chairman & GM01980

Description

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.